[1] Conejo I, Guardascione Ma, Tandon P, et al. Multicenter external validation of risk stratification criteria for patients with variceal bleeding[J]. Clin Gastroenterol Hepatol, 2018,16(1):132-139. DOI: 10.1016/j.cgh.2017.04.042.
[2] Lv Y, Zuo L, Zhu X, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study[J]. Gut, 2019, 68(7):1297-1310. DOI: 10.1136/gutjnl-2018-317057.
[3] Ardevol A, Ibañez-Sanz G, Profitos J, et al. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies[J]. Hepatology,2018, 67(4):1458-1471. DOI: 10.1002/hep.29370.
[4] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis,and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology,2017, 65(1):310-335. DOI: 10.1002/hep.28906.
[5] 吕勇, 韩国宏, 樊代明 . 经颈内静脉肝内门体分流术治疗肝硬化食管胃静脉曲张出血的最适人群和时机[J]. 中华肝脏病杂志, 2017, 25(6):402-407. DOI: 10.3760/cma.j.issn.1007-3418.2017.06.002.
[6] de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension[J]. J Hepatol,2015, 63(3):743-752. DOI: 10.1016/j.jhep.2015.05.022.
[7] Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients[J]. Gut,2015, 64(11):1680-1704. DOI: 10.1136/gutjnl-2015-309262.
[8] 徐小元, 丁惠国, 贾继东, 等 . 肝硬化门静脉高压食管胃静脉曲张 出 血 的 防 治 指 南 [J]. 实用 肝 脏 病 杂 志 , 2016, 19(5):641-656.
[9] Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding[J]. N Engl J Med, 2013, 368(1):11-21. DOI: 10.1056/NEJMoa1211801.
[10] Odutayo A, Desborough MJ, Trivella M, et al. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials[J]. Lancet Gastroenterol Hepatol, 2017, 2(5):354-360.DOI: 10.1016/S2468-1253(17)30054-7.
[11] O'Leary JG, Greenberg CS, Patton HM, et al. AGA clinical practice update: coagulation in cirrhosis[J]. Gastroenterology, 2019, 157(1):34-43. DOI: 10.1053/j.gastro.2019.03.070.
[12] Bendtsen F, D'Amico G, Rusch E, et al. Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials[J]. J Hepatol, 2014, 61(2):252-259. DOI: 10.1016/j.jhep.2014.03.035.
[13] Azam Z, Hamid S, Jafri W, et al. Short course adjuvant terlipressin in acute variceal bleeding: a randomized doubleblind dummy controlled trial[J]. J Hepatol, 2012, 56(4):819-824.DOI: 10.1016/j.jhep.2011.11.019.
[14] Seo YS, Park SY, Kim MY, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage[J]. Hepatology,2014, 60(3):954-963. DOI: 10.1002/hep.27006.
[15] Huh CW, Kim JS, Jung DH, et al. Optimal endoscopy timing according to the severity of underlying liver disease in patients with acute variceal bleeding[J]. Dig Liver Dis, 2019, 51(7):993-998. DOI: 10.1016/j.dld.2019.01.013.
[16] European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2):406-460.DOI: 10.1016/j.jhep.2018.03.024.
[17] Ibrahim M, El-Mikkawy A, Mostafa I, et al. Endoscopic treatment of acute variceal hemorrhage by using hemostatic powder TC-325: a prospective pilot study[J]. Gastrointest Endosc, 2013, 78(5):769-773. DOI: 10.1016/j.gie.2013.07.037.
[18] Ibrahim M, El-Mikkawy A, Abdel H, et al. Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial[J]. Gut, 2019, 68(5):844-853. DOI: 10.1136/gutjnl-2017-314653.
[19] Thalheimer U, Triantos CK, Samonakis DN, et al. Infection, coagulation, and variceal bleeding in cirrhosis[J]. Gut, 2005, 54(4):556-563. DOI: 10.1136/gut.2004.048181.
[20] Fernández J, Tandon P, Mensa J, et al. Antibiotic prophylaxis in cirrhosis: Good and bad[J]. Hepatology, 2016, 63(6):2019-2031.DOI: 10.1002/hep.28330.
[21] Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-an updated cochrane review[J]. Aliment Pharmacol Ther, 2011, 34(5): 509-518. DOI: 10.1111/j.1365-2036.2011.04746.x.
[22] Tandon P, Abraldes JG, Keough A, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics[J]. Clin Gastroenterol Hepatol, 2015, 13(6):1189-1196. DOI: 10.1016/j.cgh.2014.11.019.
[23] Sharma P, Agrawal A, Sharma Bc, et al. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose[J]. J Gastroenterol Hepatol, 2011, 26(6):996-1003. DOI: 10.1111/j.1440-1746.2010.06596.x.
[24] Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy[J]. N Engl J Med, 2010, 362(12): 1071-1081. DOI: 10.1056/NEJMoa0907893.
[25] Kumar R, Kerbert A, Sheikh M, et al. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding[J]. Journal of Hepatology, 2021, 74(1): 66-79. DOI: 10.1016/j.jhep.2020.06.010.
[26] Bosch J, Sauerbruch T. Esophageal varices: stage-dependent treatment algorithm[J]. J Hepatol, 2016, 64(3):746-748. DOI:10.1016/j.jhep.2015.11.039.
[27] Marot A, Trépo E, Doerig C, et al. Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding [J]. Aliment Pharmacol Ther, 2015, 42(11-12):1250-1260. DOI:10.1111/apt.13424.
[28] Escorsell À, Pavel O, Cárdenas A, et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial[J].Hepatology, 2016, 63(6):1957-1967. DOI: 10.1002/hep.28360.
[29] D'Amico G, Morabito A, D'Amico M, et al. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis[J]. Hepatol Int, 2018, 12(Suppl 1):34-43. DOI: 10.1007/s12072-017-9808-z.
[30] Reverter E, Genesca J, Augustin S, et al. Risk stratification in acute variceal bleeding: Child-Pugh versus model for end-stage liver disease[J]. J Clin Gastroenterol, 2019, 53(7): 549. DOI:10.1097/MCG.0000000000000815.
[31] Magaz M, Baiges A, Hernández-Gea V. Precision medicine in variceal bleeding: are we there yet?[J]. J Hepatol, 2020, 72(4):774-784. DOI: 10.1016/j.jhep.2020.01.008.
[32] Robertson M, Ng J, Abu S, et al. Risk stratification in acute variceal bleeding: comparison of the AIMS65 score to established upper gastrointestinal bleeding and liver disease severity risk stratification scoring systems in predicting mortality and rebleeding[J]. Dig Endosc, 2020, 32(5):761-768.DOI: 10.1111/den.13577.
[33] Garcia-Tsao G. Management of acute variceal hemorrhage as a model of individualized care for patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2018, 16(1):24-26. DOI: 10.1016/j.cgh.2017.08.035.
[34] Rudler M, Bureau C, Carbonell N, et al. Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding[J]. Liver Int, 2018, 38(3): 469-476. DOI: 10.1111/liv.13632.
[35] Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding[J]. Gastroenterology, 2014, 146(2):412-419.DOI: 10.1053/j.gastro.2013.10.018.
[36] Trebicka J, Gu W, Ibáñez-Samaniego L, et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS[J]. Hepatol, 2020, 73(5): 1082-1091. DOI: 10.1016/j.jhep.2020.04.024.
[37] Lv Y, Wang Z, Li K, et al. Risk stratification based on chronic liver failure consortium acute decompensation score in
patients with Child-Pugh B cirrhosis and acute variceal bleeding[J]. Hepatology, 2021, 73(4): 1478-1493. DOI: 10.1002/hep.31478.
[38] Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding[J]. J Hepatol, 2002, 37(5):703-704.
[39] Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis[J]. J Hepatol,2001, 35(5):590-597.
[40] Bosch J. Salvage transjugular intrahepatic portosystemic shunt:is it really life-saving?[J]. J Hepatol, 2001, 35(5):658-660.
[41] Monescillo A, Martinez-Lagares F, Ruiz-Del-Arbol L, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding[J]. Hepatology, 2004, 40(4):793-801. DOI: 10.1002/hep.20386.
[42] Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding[J]. N Engl J Med, 2010, 362(25):2370-2379. DOI: 10.1056/NEJMoa0910102.
[43] Rudler M, Cluzel P, Corvec TL, et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival[J]. Aliment Pharmacol Ther, 2014, 40(9):1074-1080. DOI: 10.1111/apt.12934.
[44] Hernandez-Gea V, Procopet B, Giraldez A, et al. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study[J]. Hepatology, 2019, 69(1):282-293. DOI: 10.1002/hep.30182.
[45] Garcia-Pagan JC, Di Pascoli M, Caca K, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study[J]. J Hepatol, 2013, 58(1):45-50.DOI: 10.1016/j.jhep.2012.08.020.
[46] Lv Y, Yang Z, Liu L, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial [J]. Lancet Gastroenterol Hepatol, 2019, 4(8):587-598. DOI:10.1016/S2468-1253(19)30090-1.
[47] Nicoară -Farcău O, Han G, Rudler M, et al. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data[J]. Gastroenterology, 2021, 160(1):193-205. DOI: 10.1053/j.gastro.2020.09.026.
[48] Conejo I, Guardascione MA, Tandon P, et al. Multicenter external validation of risk stratification criteria for patients with variceal bleeding[J]. Clin Gastroenterol Hepatol, 2018,16(1):132-139. DOI: 10.1016/j.cgh.2017.04.042.
[49] Thabut D, Pauwels A, Carbonell N, et al. Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results[J]. J Hepatol, 2018, 68:73-81. DOI: 10.1016/j.jhep.2017.09.002.